GKIM
OYST

GW&K Investment Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

GW&K Investment Management’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-554,288
Closed -$6.19M – 641
2022
Q4 		$6.19M Sell
554,288
-10,568
-2% -$102K 0.06% 247
2022
Q3 		$3.17M Buy
564,856
+100,473
+22% +$629K 0.04% 271
2022
Q2 		$2.01M Buy
464,383
+10,216
+2% +$58.1K 0.02% 307
2022
Q1 		$5.29M Buy
454,167
+83,383
+22% +$993K 0.05% 247
2021
Q4 		$6.77M Sell
370,784
-17,946
-5% -$228K 0.06% 240
2021
Q3 		$4.61M Sell
388,730
-5,483
-1% -$79.9K 0.04% 272
2021
Q2 		$6.78M Sell
394,213
-8,070
-2% -$153K 0.06% 247
2021
Q1 		$7.35M Buy
402,283
+51,357
+15% +$1.08M 0.07% 235
2020
Q4 		$6.6M Buy
350,926
+68,219
+24% +$1.47M 0.07% 244
2020
Q3 		$5.97M Buy
282,707
+127,274
+82% +$2.98M 0.08% 235
2020
Q2 		$4.49M Buy
+155,433
New +$4.68M 0.06% 241

Other funds holding OYST

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

GW&K Investment Management's OYST Position: Q1 2023 in Review

GW&K Investment Management sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 554,288 shares — an estimated $6.19M sold.

GW&K Investment Management first reported a position in OYST in Q2 2020 and held it in 11 quarters. The position peaked at $7.35M in Q1 2021. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

  • GW&K Investment Management reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • GW&K Investment Management sold 554,288 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $6.19M.
  • GW&K Investment Management first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 11 quarters.
  • GW&K Investment Management's Oyster Point Pharma, Inc. Common Stock position peaked at $7.35M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on GW&K Investment Management's 13F filing for Q1 2023, filed 9 May 2023.